However, an anti-PD-L1:TGF-β trap fusion protein directly targeting MSS-positive metastatic CRC failed to control the recurrence of ctDNA and, instead, elevated the level of ctDNA (86). Here, TGFB1 is linked to colorectal carcinoma.